In this open-label , pragmatic trial , we randomly assigned 230 children , 1 to 10 years of age , who had acute tympanostomy-tube otorrhea to receive hydrocortisone-bacitracin-colistin eardrops ( 76 children ) or oral amoxicillin-clavulanate suspension ( 77 ) or to undergo initial observation ( 77 ) .